Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 1
1967 6
1968 3
1969 7
1970 7
1971 8
1972 12
1973 11
1974 11
1975 21
1976 17
1977 16
1978 21
1979 14
1980 24
1981 18
1982 30
1983 40
1984 49
1985 39
1986 54
1987 55
1988 56
1989 53
1990 65
1991 84
1992 100
1993 133
1994 123
1995 95
1996 104
1997 110
1998 115
1999 116
2000 102
2001 111
2002 85
2003 115
2004 120
2005 138
2006 142
2007 138
2008 134
2009 129
2010 141
2011 125
2012 140
2013 144
2014 161
2015 160
2016 141
2017 161
2018 146
2019 120
2020 108
2021 127
2022 110
2023 21
Text availability
Article attribute
Article type
Publication date

Search Results

4,259 results
Results by year
Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Prednisolone Versus Dexamethasone for Croup: a Randomized Controlled Trial.
Parker CM, Cooper MN. Parker CM, et al. Pediatrics. 2019 Sep;144(3):e20183772. doi: 10.1542/peds.2018-3772. Epub 2019 Aug 15. Pediatrics. 2019. PMID: 31416827 Clinical Trial.
OBJECTIVES: The use of either prednisolone or low-dose dexamethasone in the treatment of childhood croup lacks a rigorous evidence base despite widespread use. ...Re-attendance rates were 17.8% for dexamethasone, 19.5% for low-dose dexamethasone, and 21.7% for prednisol
OBJECTIVES: The use of either prednisolone or low-dose dexamethasone in the treatment of childhood croup lacks a rigorous evidence ba …
Randomized, Controlled Trial of Tacrolimus and Prednisolone Monotherapy for Adults with De Novo Minimal Change Disease: A Multicenter, Randomized, Controlled Trial.
Medjeral-Thomas NR, Lawrence C, Condon M, Sood B, Warwicker P, Brown H, Pattison J, Bhandari S, Barratt J, Turner N, Cook HT, Levy JB, Lightstone L, Pusey C, Galliford J, Cairns TD, Griffith M. Medjeral-Thomas NR, et al. Clin J Am Soc Nephrol. 2020 Feb 7;15(2):209-218. doi: 10.2215/CJN.06180519. Epub 2020 Jan 17. Clin J Am Soc Nephrol. 2020. PMID: 31953303 Free PMC article. Clinical Trial.
RESULTS: There were no significant differences between the tacrolimus and prednisolone treatment cohorts in the proportion of patients in complete remission at 8 weeks (21 out of 25 [84%] for prednisolone and 17 out of 25 [68%] for tacrolimus cohorts; P=0.32; differ …
RESULTS: There were no significant differences between the tacrolimus and prednisolone treatment cohorts in the proportion of patient …
Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.
Webb NJ, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Wheatley K, Ives NJ. Webb NJ, et al. Health Technol Assess. 2019 May;23(26):1-108. doi: 10.3310/hta23260. Health Technol Assess. 2019. PMID: 31156083 Free PMC article. Clinical Trial.
INTERVENTIONS: The control group (n = 118) received standard course (SC) prednisolone therapy: 60 mg/m(2)/day of prednisolone in weeks 1-4, 40 mg/m(2) of prednisolone on alternate days in weeks 5-8 and matching placebo on alternate days in weeks 9-18 (total 2 …
INTERVENTIONS: The control group (n = 118) received standard course (SC) prednisolone therapy: 60 mg/m(2)/day of prednisolone
Corticosteroid therapy of alcoholic hepatitis.
Maddrey WC, Boitnott JK, Bedine MS, Weber FL Jr, Mezey E, White RI Jr. Maddrey WC, et al. Gastroenterology. 1978 Aug;75(2):193-9. Gastroenterology. 1978. PMID: 352788 Clinical Trial.
Fifty-five patients with alcoholic hepatitis were studied in a 28- to 32-day randomized double blind treatment trial comparing prednisolone (40 mg per day) with placebo therapy. Of 31 placebo-treated patients, 4 died during the study interval and 2 more died within 5 days …
Fifty-five patients with alcoholic hepatitis were studied in a 28- to 32-day randomized double blind treatment trial comparing prednisolo
Prednisolone and budesonide for short- and long-term treatment of microscopic colitis: systematic review and meta-analysis.
Stewart MJ, Seow CH, Storr MA. Stewart MJ, et al. Clin Gastroenterol Hepatol. 2011 Oct;9(10):881-90. doi: 10.1016/j.cgh.2011.06.005. Epub 2011 Jun 13. Clin Gastroenterol Hepatol. 2011. PMID: 21699817 Review.
A total of 248 patients were randomized to corticosteroid versus placebo. The intervention was budesonide in 7 trials and prednisolone in 1 trial. Budesonide was significantly more effective than placebo for short-term clinical response (risk ratio [RR], 3.07; 95% confiden …
A total of 248 patients were randomized to corticosteroid versus placebo. The intervention was budesonide in 7 trials and prednisolone
Corticosteroids for Guillain-Barré syndrome.
Hughes RA, Brassington R, Gunn AA, van Doorn PA. Hughes RA, et al. Cochrane Database Syst Rev. 2016 Oct 24;10(10):CD001446. doi: 10.1002/14651858.CD001446.pub5. Cochrane Database Syst Rev. 2016. PMID: 27775812 Free PMC article. Review.
Serum biomarkers in prednisolone-treated hand osteoarthritis patients.
van de Stadt LA, Kroon FPB, Thudium CF, Bay-Jensen AC, Kloppenburg M. van de Stadt LA, et al. Rheumatology (Oxford). 2023 Mar 1;62(3):1350-1355. doi: 10.1093/rheumatology/keac442. Rheumatology (Oxford). 2023. PMID: 35946535 Free PMC article. Clinical Trial.
OBJECTIVES: To investigate whether biomarkers are modulated by prednisolone treatment in patients with hand OA and whether they can predict response to prednisolone. ...CONCLUSION: Erosive disease was associated with higher levels of C1M and hsCRP. Biomarker levels …
OBJECTIVES: To investigate whether biomarkers are modulated by prednisolone treatment in patients with hand OA and whether they can p …
The value of prednisolone acetate provocative test before intravitreal triamcinolone acetonide injections.
Saady AM, Fouad HM, Abdullatif AM, Helmy YAH, Macky TA, Mansour K. Saady AM, et al. Eur J Ophthalmol. 2020 Jul;30(4):730-737. doi: 10.1177/1120672119842731. Epub 2019 Apr 12. Eur J Ophthalmol. 2020. PMID: 30977377 Clinical Trial.
Patients scheduled for intravitreal triamcinolone acetonide were enrolled and randomly allocated in a ratio 2:1 to either Group A: received prednisolone acetate provocative test and those who did not develop SIOH proceeded with intravitreal triamcinolone acetonide or Group …
Patients scheduled for intravitreal triamcinolone acetonide were enrolled and randomly allocated in a ratio 2:1 to either Group A: received …
The effect of prednisolone on symptom severity in schizophrenia: A placebo-controlled, randomized controlled trial.
Nasib LG, Gangadin SS, Rossum IW, Boudewijns ZSRM, de Witte LD, Wilting I, Luykx J, Somers M, Veen N, van Baal C, Kahn RS, Sommer IE. Nasib LG, et al. Schizophr Res. 2021 Apr;230:79-86. doi: 10.1016/j.schres.2021.01.024. Epub 2021 Mar 10. Schizophr Res. 2021. PMID: 33711681 Free article. Clinical Trial.
RESULTS: In total, 68 patients signed informed consent and were screened on eligibility criteria, of whom 42 patients were randomized to either prednisolone or placebo, with 39 patients completing the treatment and tapering phase. ...CONCLUSION: Adjunctive treatment with …
RESULTS: In total, 68 patients signed informed consent and were screened on eligibility criteria, of whom 42 patients were randomized to eit …
Short-Duration Prednisolone in Children with Nephrotic Syndrome Relapse: A Noninferiority Randomized Controlled Trial.
Kainth D, Hari P, Sinha A, Pandey S, Bagga A. Kainth D, et al. Clin J Am Soc Nephrol. 2021 Feb 8;16(2):225-232. doi: 10.2215/CJN.06140420. Epub 2021 Jan 21. Clin J Am Soc Nephrol. 2021. PMID: 33478976 Free PMC article. Clinical Trial.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In a single-center, open-label, randomized controlled trial, we evaluated the efficacy of prednisolone as a "short regimen" (40 mg/m(2) on alternate days for 2 weeks) compared with "standard regimen" (40 mg/m(2) on alterna …
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In a single-center, open-label, randomized controlled trial, we evaluated the efficacy of …
4,259 results